Navigation Links
Company Appoints New SVP, Marketing for PBM Business
Date:11/4/2009

WOONSOCKET, R.I., Nov. 4 /PRNewswire/ -- CVS Caremark (NYSE: CVS) today announced the appointment of Len Greer to the position of SVP, Marketing for its pharmacy benefit management business. Greer assumes responsibility for the company's PBM marketing from Jack Bruner, who is transitioning to the new role of EVP, Strategic Development.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO )

Greer brings twenty years of experience in marketing, strategy and product development to CVS Caremark. He joins the company from ActiveHealth where he was the EVP, Marketing responsible for developing and implementing marketing strategies to drive brand awareness in the health plan and plan sponsor marketplace. Prior to his tenure with ActiveHealth he spent six years at Medco Health in various senior marketing roles. Before joining Medco, Greer was a management consultant at McKinsey & Company, where he assisted clients on issues of marketing, strategy, product development and operations.

"Len's analytical background, knowledge of the industry and strong marketing skills make him uniquely qualified to help deliver our messages effectively in the marketplace," commented Tom Ryan, President, Chairman and CEO.

Len holds a bachelor's degree from the Illinois Institute of Technology and a master's degree in business administration from the University of Michigan.

About CVS Caremark

CVS Caremark is the largest provider of prescriptions in the nation. The Company fills or manages more than 1 billion prescriptions annually. Through its unmatched breadth of service offerings, CVS Caremark is transforming the delivery of health care services in the U.S. The Company is uniquely positioned to effectively manage costs and improve health care outcomes through its more than 7,000 CVS/pharmacy and Longs Drugs stores; its Caremark Pharmacy Services division (pharmacy benefit management, mail order and specialty pharmacy); its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, CVS.com. General information about CVS Caremark is available through the Investor Relations section of the Company's Web site, at www.cvscaremark.com/investors, as well as through the press room section of the Company's Web site, at www.cvscaremark.com/newsroom.

    Media Contact:
    Eileen Howard Dunn                  Nancy Christal
    CVS Caremark                        CVS Caremark
    Senior Vice President               Senior Vice President
    Corporate Communications            Investor Relations
    (401) 770-4561                      (914) 722-4704

SOURCE CVS Caremark


'/>"/>
SOURCE CVS Caremark
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
2. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
3. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
4. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
5. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for PYY3-36 Nasal Spray to Treat Obesity
6. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
7. Female Health Company Receives Brazilian Order: Four Million FC Female Condoms
8. The Pittsburgh Life Sciences Greenhouse Relocates Therapeutics Company to Pittsburgh
9. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
10. IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
11. Maine Natural Health Company Conducts Dental Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... PUNE, India , March 24, 2017 Abdominal Aortic ... reach $2,614 million by 2022, Globally, registering a CAGR of 5.1% from 2016 to ... and is projected to dominate the market during the study period. ... ... ...
(Date:3/24/2017)... , March 24, 2017  Zymo Research ... and Hamilton Robotics, Inc., who designs, manufactures ... ongoing collaboration that teams Zymo Research,s DNA ... and DNA extraction products with Hamilton,s high-throughput ... optimized methods for microbiomics and RNA isolation ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Dental ... ... markets for Dental Implants in US$ Million. The report provides separate comprehensive ... , Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period 2015 through ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... American Veterinarian™, the ... on veterinary medicine, announces the launch of Veterinarian’s Money Digest™, a business and ... April edition of American Veterinarian™. , “We look forward to launching ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek , a Farmingdale, ... recent RNA methylation “gold rush” with their established portfolio of optimized assay kits ... N6-methyladenosine, or m6A , RNA methylation has received a new burst in ...
(Date:3/27/2017)... ... 27, 2017 , ... According to the American Cancer Society , the ... than 95%. Once the cancer spreads to other organs, bones, or lymph nodes, however, ... to avoid this latter group, tune in to Lifestyle Magazine on April ...
(Date:3/27/2017)... ... March 27, 2017 , ... ?Grow Healthy ... resolve the pending litigation between itself and 1800 Vending DBA Healthy You Vending. ... “I am thrilled to announce that we have now reached a settlement agreement ...
(Date:3/27/2017)... ... March 27, 2017 , ... Harris Communications, Inc., a leading ... bringing its latest products to the Deaf Seniors of America Conference, April 4-7 at ... to meet with knowledgeable ASL friendly staff from Harris Communications and to try out ...
Breaking Medicine News(10 mins):